Antje Danielczyk
15Patents
5h-index
16Co-inventors
63Inventor score
Filing activity: Dec 1, 2003 → Jul 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8088357B2 | Tumor-specific recognition molecules | Chemistry; Metallurgy | 17 | Active |
| US9051356B2 | Use of human cells of myeloid leukaemia origin for expression of antibodies | Emerging Cross-Sectional Technologies | 7 | Active |
| US9845361B2 | Recognition molecules for the treatment and detection of tumors | Chemistry; Metallurgy | 6 | Active |
| US9051370B2 | Humanized EGFR antibodies | Chemistry; Metallurgy | 5 | Active |
| US9217038B2 | MUC1 antibodies | Chemistry; Metallurgy | 5 | Active |
| US9359439B2 | Fab-glycosylated antibodies | Chemistry; Metallurgy | 5 | Active |
| US10280230B2 | Use of human cells of myeloid leukemia origin for expression of antibodies | Emerging Cross-Sectional Technologies | 4 | Active |
| US8779102B2 | Recognition molecules for the treatment and detection of tumors | Chemistry; Metallurgy | 4 | Expired |
| US9345794B2 | Tumor-specific recognition molecules | Chemistry; Metallurgy | 4 | Active |
| US8617846B2 | Tumor-specific recognition molecules | Chemistry; Metallurgy | 4 | Active |
| US11872289B2 | Anti-MUC1 antibody-drug conjugate | Chemistry; Metallurgy | 2 | Active |
| US10184135B2 | Eukaryotic expression vectors comprising regulatory elements of the globin gene clusters | Chemistry; Metallurgy | 0 | Active |
| US12297289B2 | Anti-MUC1 antibody | Chemistry; Metallurgy | 0 | Active |
| US12291577B2 | Anti-MUC1 antibody-drug conjugate | Chemistry; Metallurgy | 0 | Active |
| US12415864B2 | Humanized antibodies against Lewis Y | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.